Duncan Low joined the Process Development Department at Amgen in 2003, where he is currently responsible for Materials Science. He leads cross-functional teams for materials and technology evaluation, technology development and Process Analytical Technology. He is a member of the ISPE Executive Committee for PAT and the biotech PQLI team, a member of USP’s Committee of Experts and chairs the ASTM E55.01 subcommittee developing consensus standards for Manufacture of Pharmaceutical Products. Prior to joining Amgen he held VP positions at Millipore and Pharmacia Biotech. He has extensive experience of the tools currently in use in upstream and downstream processing and has worked closely with applications development throughout the industry. He has an M.A. in biochemistry from the University of Cambridge and a Ph.D. in microbiology from the University of Glasgow.